Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials

Dear Colleagues,

We are pleased to announce this Topical Collection, titled “Editorial Board Members' Collection Series: Structural aspects of AMPs and antimicrobials”. This issue is dedicated to collecting papers from the Editorial Board Members. In the context of the rising global incidence of antibiotic resistance, antimicrobial peptides (AMPs), peptidomimetics and polymers have been proposed as realistic alternatives to conventional antibiotics. Conventional antibiotics target enzymes and proteins with resistance frequently arising from structural mutations. In contrast, antimicrobial peptides/peptidomimetics/polymers by virtue of their different targets (for example the bacterial membrane or nucleic acids) are active on antibiotic-resistant strains and are less likely to produce resistance. In addition, antimicrobial peptides/peptidomimetics/polymers are multifunctional and may possess additional activities such as wound healing, anti-inflammatory, antifungal, antiviral, antitumoral or antibiofilm properties and may act synergistically with conventional antibiotics. The aim of this Topical Collection is to provide a venue for networking and communication between Antibiotics and scholars in the field of structural aspects of antimicrobial peptides. Topics of interest include, but are not limited to, the following:

• Diversity of origin of antimicrobial agents (natural peptides, ribosomally produced, ribosomally synthesized and posttranslationally modified peptides non-ribosomally produced peptides), synthetic peptides, peptidomimetics, antimicrobial polymers)
• Diversity of conformation of antimicrobial peptides, peptidomimetics and polymers (helical, beta sheet, beta hairpin etc)
• Diversity of activity of antimicrobial peptides, peptidomimetics and polymers (antibacterial, antifungal, antiviral, antitumoral, anti-inflammatory, antibiofilm, wound healing, synergy with antibiotics) 
• Peptidase-resistance
• Host-defense, Innate immunity
• Cytotoxicity
• Bacterial antitoxins; Toxin-antitoxin complex; Antitoxin inhibition
• Allostery
• Circular Dichroism
• NMR

Prof. Dr. J. Michael Conlon
Dr. Marc Maresca
Prof. Dr. Bong-Jin Lee
Dr. Aurélie Tasiemski
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.